Literature DB >> 8985664

Medium and supplement effects on the antimicrobial activity of quinupristin/dalfopristin tested by agar dilution and Etest methods.

R N Jones1.   

Abstract

Quinupristin/dalfopristin (also known as RP-59500 and Synercid), a streptogramin combination has been documented as active against a wide variety of Gram-positive species. Broad ranges of MIC results have been observed with some species using acceptable susceptibility testing methods. To address the contribution of testing medium and supplements to this disagreement, 15 medium or supplement alterations were studied in a reference agar dilution format and three variations of Mueller-Hinton agar were used for Etest (AB Biodisk, Solna, Sweden). One-third of the agar dilution variations produced a consistent elevation (twofold) in the quinupristin/dalfopristin MIC. The greatest changes were secondary to additions of serum and blood, pH increases, and possibly charcoal. Similarly, the Etest MICs for quinupristin/dalfopristin were 0.5 to 2.5 log2 dilutions higher with media supplemented with 5% sheep erythrocytes or when chocolated. Additional quinupristin/dalfopristin stability experiments in three agars indicate a two- to fourfold decline in potency over 21 days of storage at 2 to 5 degrees C. These variations in the streptogramin MIC results would be observed most frequently when testing fastidious species or in laboratories routinely testing all Gram-positive bacteria in or on blood-supplemented media.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8985664     DOI: 10.1016/s0732-8893(96)00179-4

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

Review 1.  Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Authors:  H M Lamb; D P Figgitt; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Analysis of MIC and Disk Diffusion Testing Variables for Gepotidacin and Comparator Agents against Select Bacterial Pathogens.

Authors:  L M Koeth; J M DiFranco-Fisher; N E Scangarella-Oman; L A Miller
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

3.  Antimicrobial properties of garlic oil against human enteric bacteria: evaluation of methodologies and comparisons with garlic oil sulfides and garlic powder.

Authors:  Z M Ross; E A O'Gara; D J Hill; H V Sleightholme; D J Maslin
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.